Type 2 Diabetes

Study looks at convenient once-weekly GLP-1 that can reduce chances of heart attacks and strokes.

The SUMMIT VIP study shows conventional risk factors do not suffice in predicting heart complications.

Study shows mice with obesity and type 2 have significantly slower healing of wounds compared to those with undisturbed sleep.

Medications suggested for second- and third-line treatments for diabetes management following treatment failure with metformin and sulfonylureas.

Thorough knowledge of anti-diabetes medications found to lead to better management, adherence.

In part 2 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the educational benefit from using CGM for type 2 diabetes.

Investigators find patients treated with GLP-1 drug had significantly lower number of amputations compared to placebo group.

Recent study shows improvements in insulin resistance and endotoxin-induced inflammation after taking probiotic supplementation, compared to placebo.

Recent studies show continued benefit in decreasing all-cause mortality from cardiovascular disease.

People with type 2 diabetes found at increased risk for microvascular and macrovascular complications.